CD34 is primarily known as a biomarker for hematopoietic stem cells (HSCs) and hematopoietic stem precursor cells, but it has also been identified as a marker for several non-hematopoietic …

CD34 is a transmembrane phosphoglycoprotein, first identified on hematopoietic stem and progenitor cells. Clinically, it is associated with the selection and enrichment of hematopoietic …

2024年12月24日 · CD34 (CD34 Molecule) is a Protein Coding gene. Diseases associated with CD34 include Dermatofibrosarcoma Protuberans and Cutaneous Fibrous Histiocytoma. …

2017年12月26日 · For almost 30 years, the cell-surface sialomucin CD34 has been used as a marker to identify and enrich HSPCs in preparation for BM transplantation. 1 However, studies …

CD34 is a marker of human HSC, and all colony-forming activity of human bone marrow (BM) cells is found in the CD34+ fraction. Clinical transplantation studies that used enriched CD34+ …

CD34 is a transmembrane glycoprotein that is expressed on early lymphohematopoietic stem cells, progenitor cells, endothelial cells, embryonic fibroblasts, and some cells in fetal and adult …

2023年8月19日 · The sialomucin, CD34, is widely used as an endothelial marker. However, CD34 is differentially expressed on endothelial cells in different organs and in pathological conditions.

2023年7月14日 · This review recaptures CD34 structure, evolutionary conservation, proposed functions, and role in lung inflammation, to describe current research findings and to provide …

CD34 is a type I transmembrane glycophosphoprotein that has been used as the hallmark for clinical identification and enrichment of hematopoietic stem cells for several years (Sato et al., …

2023年5月12日 · CD34 is commonly used as a marker to identify and isolate CSCs in various types of cancer. CD34-positive CSCs have been identified in leukemia, breast cancer, lung …